Search

everythinglearnresearchcommunity

for

Search:↓

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.